Who invested in GlycoVaxyn?
GlycoVaxyn's investors include Index Ventures, Sofinnova Partners and Edmond de Rothschild Venture Capital.
Switzerland · Series B startup
Funding summaryUpdated 26 Oct 2026
$32Mraised across 3 rounds since 2006, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by bio-medicine.org
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
GlycoVaxyn's investors include Index Ventures, Sofinnova Partners and Edmond de Rothschild Venture Capital.
GlycoVaxyn has raised $32M across 3 rounds since 2006.
GlycoVaxyn's most recent round was a Series B of $21M in Mar 2009.
Its most recent round, $21M in Mar 2009, is also its largest on record.
GlycoVaxyn's first round on record, in Jul 2006, was backed by Index Ventures and Sofinnova Partners.
GlycoVaxyn's latest named round is a Series B, in Mar 2009.
GlycoVaxyn is based in Switzerland.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.